Saint Paul, MN, United States of America

Cameron McDonald-Hyman

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: New York University, Regents of the University of Minnesota. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Cameron McDonald-Hyman. Retrieved from https://idiyas.com/inventor/cameron-mcdonald-hyman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Cameron McDonald-Hyman: Innovator in Regulatory T-Cell Function

Introduction

Cameron McDonald-Hyman is a notable inventor based in Saint Paul, MN (US). He has made significant contributions to the field of immunology, particularly in enhancing the function of regulatory T-cells (Tregs). His innovative work has implications for various therapeutic applications.

Latest Patents

Cameron holds 1 patent titled "Methods and compositions for increasing the suppressive function of regulatory T-cells (Tregs)." This patent provides methods and compositions aimed at enhancing the suppressive function of Tregs, which are crucial for maintaining immune system balance.

Career Highlights

Throughout his career, Cameron has worked with esteemed institutions such as the Regents of the University of Minnesota and New York University. His experience in these organizations has allowed him to collaborate with leading experts in the field.

Collaborations

Cameron has had the opportunity to work alongside notable colleagues, including Bruce Robert Blazar and Michael Dustin. Their combined expertise has contributed to advancements in immunological research.

Conclusion

Cameron McDonald-Hyman's work in the field of regulatory T-cells exemplifies the impact of innovative research on medical science. His contributions continue to pave the way for future advancements in immunotherapy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…